LENZ Therapeutics discusses Q4 2024 earnings expectations

March 19, 2025, was the date of LENZ Therapeutics' conference call to discuss its financial results for the fourth quarter of 2024. The call included key executives such as Dan Chevallard, the Chief Financial Officer, Eef Schimmelpennink, the CEO, Shawn Olsson, the Chief Commercial Officer, and Marc Odrich, the Chief Medical Officer. During the call, Chevallard emphasized that the company would provide forward-looking statements. These statements relate to future plans, expectations, and financial projections. However, he noted that actual results could differ significantly due to various risks and factors. Executives were on hand to answer questions after their prepared remarks. They welcomed inquiries from analysts, which indicated keen interest in LENZ's performance. The call aimed to inform stakeholders about the company's financial health and strategic direction.